SIGA 📈 SIGA Technologies - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8269171067
SIGA: Antiviral, Smallpox, Treatment, Medicine, Pharmaceuticals
SIGA Technologies Inc, a pharmaceutical company with a commercial presence, specializes in addressing health security concerns in the United States. At the forefront of its product portfolio is TPOXX, an innovative oral antiviral medication designed to combat human smallpox disease caused by the variola virus.
As a pioneer in the health security space, SIGA Technologies has been dedicated to developing critical solutions since its inception in 1995. With its headquarters in New York, New York, the company has established itself as a key player in the pharmaceutical industry, committed to protecting public health and national security.
Through its cutting-edge research and development, SIGA Technologies has demonstrated a strong focus on creating novel treatments for high-priority health threats. With TPOXX as its flagship product, the company has made significant strides in addressing the risks associated with smallpox, a highly contagious and potentially devastating disease.
For more information on SIGA Technologies and its mission to enhance health security, please visit their official website at https://www.siga.com.
Additional Sources for SIGA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SIGA Stock Overview
| Market Cap in USD | 504m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| GiC Industry | Pharmaceuticals |
| TER | 0.00% |
| IPO / Inception | 1997-09-09 |
SIGA Stock Ratings
| Growth 5y | 41.5% |
| Fundamental | 64.1% |
| Dividend | 80.4% |
| Rel. Performance Sector | 1.38 |
| Analysts | - |
| Fair Price Momentum | 6.52 USD |
| Fair Price DCF | 25.90 USD |
SIGA Dividends
| Dividend Yield 12m | 8.96% |
| Yield on Cost 5y | 17.00% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 98.33% |
SIGA Growth Ratios
| Growth Correlation 3m | -44.3% |
| Growth Correlation 12m | 39.3% |
| Growth Correlation 5y | 38.4% |
| CAGR 5y | 13.69% |
| CAGR/Mean DD 5y | 0.35 |
| Sharpe Ratio 12m | 0.66 |
| Alpha | 0.77 |
| Beta | 0.73 |
| Volatility | 108.88% |
| Current Volume | 418.4k |
| Average Volume 20d | 572.8k |
As of December 05, 2024, the stock is trading at USD 6.70 with a total of 418,367 shares traded.
Over the past week, the price has changed by -8.97%, over one month by -4.29%, over three months by -14.65% and over the past year by +24.44%.
Yes, based on ValueRay Fundamental Analyses, SIGA Technologies (NASDAQ:SIGA) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 64.07 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SIGA as of December 2024 is 6.52. This means that SIGA is currently overvalued and has a potential downside of -2.69%.
SIGA Technologies has no consensus analysts rating.
According to ValueRays Forecast Model, SIGA SIGA Technologies will be worth about 7.2 in December 2025. The stock is currently trading at 6.70. This means that the stock has a potential upside of +7.31%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 17.5 | 161.6% |
| Analysts Target Price | 17.7 | 164.2% |
| ValueRay Target Price | 7.2 | 7.3% |